Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
24%
OVERLAP
BY WEIGHT
34
# OF OVERLAPPING
HOLDINGS
XBI
141
HOLDINGS
25%
ALSO IN CANC
CANC
55
HOLDINGS
62%
ALSO IN XBI
SECTOR DRIFT (XBI minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ERASCA, INC. | 1.3% | 1.8% | 1.3% |
|
CG ONCOLOGY, INC. | 1.3% | 2.7% | 1.3% |
|
REVOLUTION MEDICINES, INC. | 1.2% | 6.0% | 1.2% |
|
BRIDGEBIO PHARMA, INC. | 1.2% | 2.6% | 1.2% |
|
RELAY THERAPEUTICS, INC. | 1.2% | 1.8% | 1.2% |
XBI Overweight Relative to CANC
|
APOGEE THERAPEUTICS, INC. | 1.5% |
|
KYMERA THERAPEUTICS, INC. | 1.4% |
|
MODERNA, INC. | 1.4% |
|
VIKING THERAPEUTICS, INC. | 1.3% |
|
ORUKA THERAPEUTICS INC | 1.3% |
|
TWIST BIOSCIENCE CORP. | 1.2% |
|
SPYRE THERAPEUTICS INC | 1.2% |
|
MIRUM PHARMACEUTICALS, INC. | 1.2% |
|
SCHOLAR ROCK HOLDING CORP. | 1.2% |
|
VAXCYTE, INC. | 1.2% |
XBI Underweight Relative to CANC
|
ELI LILLY & CO | -5.0% |
|
REVOLUTION MEDICINES, INC. | -4.8% |
 |
NOVARTIS AG | -4.0% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -3.8% |
|
COGENT BIOSCIENCES INC | -3.7% |
|
MERCK & CO. INC. | -3.4% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -3.4% |
|
JOHNSON & JOHNSON | -3.3% |
|
BRISTOL-MYERS SQUIBB CO | -3.2% |
 |
ASTRAZENECA PLC | -2.8% |